Health knowledge made personal

Mark Pool, MD

I practice general surgical pathology and serve as laboratory medical director at Riverside Medical Center in Kankakee, Illinois. I am also an adjunct attending at Rush Medical College in Chicago. My specialty challenges and humbles me because of the sublime variation and complexity of diseases... Full Bio
› Share page:

Posts

Sort by: Most recent | Name
CAP Public Comment Period for New Biomarker Reporting Checklists by Mark Pool, MD Posted in: Blog Posts in Cancer Take a look at the new cancer biomarker reporting checklists proposed by the College of American Pathologists for breast, colon and lung cancers. You don't have to be a CAP ... Read on »
Multilocular Cystic Renal Cell Carcinoma by Mark Pool, MD Posted in: Blog Posts in Cancer Multilocular cystic renal cell carcinoma is an uncommon but diagnostically challenging variant of renal cell carcinoma that fortunately has an excellent prognosis. Histologi ... Read on »
Impact of the Integrin Signaling Adaptor Protein NEDD9 on Prognosis and Metastatic Behavior of... by Mark Pool, MD Posted in: Blog Posts in Cancer Thought this was an intriguing abstract. Signaling crosstalk between EGFR and integrins was a hot topic at AACC meeting earlier this year. From Evernote: Impact of the Integ ... Read on »
Lack of NKX2-1 (TTF-1) expression in lung adenocarcinoma and EGFR mutations by Mark Pool, MD Posted in: Blog Posts in Cancer My last post discussed one of the two papers I thought were notably in the October 2012 Journal of Thoracic Oncology. Here's my take on the other paper by Vincentin et al (J ... Read on »
Loss of PTEN as a poor prognostic marker for lung adenocarcinoma by Mark Pool, MD Posted in: Blog Posts in Cancer The October 2012 Journal of Thoracic Oncology presents two papers of interest to pathologists. The first study is a paper by Yanagawa et al. that correlates PTEN expression ... Read on »
All the RAGE in Asthma by Mark Pool, MD Posted in: Blog Posts in Cancer My lab's CAP inspection is finally over!!! Now I can get back to more regular blogging (without guilt). This month's American Journal of Pathology features an intriguing art ... Read on »
Hypersensitivity Pneumonitis: recent updates by Mark Pool, MD Posted in: Blog Posts in Cancer There have been two recent papers reviewing hypersensitivity pneumonitis (HP) that I had to summarize for myself and am sharing with you. While idiopathic pulmonary fibrosis ... Read on »
Apps & Smartphones in Medical Education by Mark Pool, MD Posted in: Blog Posts in Cancer Medical students across the country are coming into a day and age where technology rules, and in a society where iPads and Android phones are voted king, it is no small wond ... Read on »
Pulmonary Arterial Enlargement and Acute Exacerbations of COPD — NEJM by Mark Pool, MD Posted in: Blog Posts in Cancer Interesting article more from the radiology perspective but it would be interesting to know if there is an autopsy study of pathological findings that would corroborate the ... Read on »
Hypermethylation in non-small cell lung carcinoma by Mark Pool, MD Posted in: Blog Posts in Cancer After an uncomfortably long hiatus from The Daily Sign-Out, I'm back. Nothing serious, just summertime distractions (fun!) and intense preparation for our lab's upcoming CAP ... Read on »
"Transfusion News" a new site launched by AABB and Ortho Clinical Diagnostics by Mark Pool, MD Posted in: Blog Posts in Cancer Check out this new web site for transfusion-related news. Excellent site design and content. AABB has partnered with Ortho Clinical Diagnostics to launch Transfusion News, a ... Read on »
Recommended Article: Health Care Reform and the Laws of Unintended Consequences by Mark Pool, MD Posted in: Blog Posts in Cancer Excellent and thoughtful post not only for those interested in healthcare policy but for anyone interested in 20th century American history. I'd be interested in checking ou ... Read on »
Evidence for lung regeneration in an adult: case report by Mark Pool, MD Posted in: Blog Posts in Cancer The conventional view is that lung growth and development ends around age 7 but a fascinating article in last week's NEJM (N Engl J Med 2012; 367:244-247July 19, 2012) sugge ... Read on »
Pathology Visions 2012: Discounted registration opportunites by Mark Pool, MD Posted in: Blog Posts in Cancer If you're thinking of attending the 2012 Pathology Visions Conference, please note the following opportunities for discounted registration fees. Here's the info provided to ... Read on »
Genetically Distinct Subsets within ANCA-Associated Vasculitis — NEJM by Mark Pool, MD Posted in: Blog Posts in Cancer Genetically Distinct Subsets within ANCA-Associated Vasculitis — NEJM. Very interesting article on overlapping, uncommon, and enigmatic clinical syndromes that have an assoc ... Read on »
Field cancerization though precancerous stromal changes by Mark Pool, MD Posted in: Blog Posts in Cancer An important question in cancer research is the causes and mechanisms for the development of multifocal carcinomas, especially for non-small cell lung carcinomas (as I recen ... Read on »
The New IASLC/ATS/ERS Lung Adenocarcinoma Classification by Mark Pool, MD Posted in: Blog Posts in Cancer FYI-Excellent content for CME In 2011, the Journal for Thoracic Oncology published the "International Association for the Study of Lung Cancer/American Thoracic Society/Euro ... Read on »
Emergent respiratory viral pathogens by Mark Pool, MD Posted in: Blog Posts in Cancer Jartii et al provide an excellent review new viral respiratory infections in the May 2012 Current Opinion in Pulmonary Medicine in you are looking for a concise update on th ... Read on »
Techniques to increase lymph node harvest from gastrointestinal cancer specimens: a systematic... by Mark Pool, MD Posted in: Blog Posts in Cancer Good news/bad news. Another article supporting the use of fat clearing and methylene blue staining to increase lymph node yields in GI dissection BUT these techniques do not ... Read on »
Proadrenomedullin in prognosis of community-acquired pneumonia by Mark Pool, MD Posted in: Blog Posts in Cancer Community-acquired pneumonia is still a major healthcare problem and is under intense scrutiny as an "opportunity" to measure hospital performance (and thus determine reimbu ... Read on »